Prasugrel Besylate

CHEMBL6068340 Phase 4 承認済み Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

531.6 g/mol

LogP

—

Phase

4

A besylate salt form of prasugrel with the same therapeutic properties. A blood-thinning medication used to prevent heart attacks and strokes in people who have had a heart attack or severe chest pain and were treated with a procedure to open blocked coronary arteries.

分子量

531.6000 g/mol

TPSA

138.00 Å²

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D構造

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(=O)Oc1cc2c(s1)CCN(C(C(=O)C1CC1)c1ccccc1F)C2.O=S(=O)(O)c1ccccc1

InChI

InChI=1S/C20H20FNO3S.C6H6O3S/c1-12(23)25-18-10-14-11-22(9-8-17(14)26-18)19(20(24)13-6-7-13)15-4-2-3-5-16(15)21;7-10(8,9)6-4-2-1-3-5-6/h2-5,10,13,19H,6-9,11H2,1H3;1-5H,(H,7,8,9)

Molecular Formula

C26H26FNO6S2

HBD / HBA

1 / 9

回転可能結合数

7

重原子数

36

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

よくある質問

A besylate salt form of prasugrel with the same therapeutic properties. A blood-thinning medication used to prevent heart attacks and strokes in people who have had a heart attack or severe chest pain and were treated with a procedure to open blocked coronary arteries.

Yes, Prasugrel Besylate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL6068340. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 24757771. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

患者向けのわかりやすい情報をお探しですか？

Prasugrel Besylate PillFYIで

構造

クイックデータ

分子式: C26H26FNO6S2

外部リンク

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

医学的免責事項

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.